In April, the Finnish Bioindustries Association appointed Maarit Merla as the new Board Chair. Only a few months earlier, Maarit became a Board Member of the Chemical Industry Federation of Finland. We wanted to have a closer look at who is Maarit Merla and what are her views on the Finnish drug development industry.
Presently, she is the Head of Business Development at Forendo Pharma, a Turku-based pharmaceutical company focusing on novel therapies for women’s health. The company has three programmes in their pipeline, the most advanced being the Endometriosis Programme, which is entering Phase 2 clinical studies. In late 2019, Forendo Pharma entered a licensing and collaboration deal with one of the world’s largest pharmaceutical companies, Novartis.
Watch below how these projects are progressing and what Maarit Merla told us about the Finnish Bioindustries Association and the planned Drug Development Centre.